Meyer A, Neumann A, Drouin J, Weill A, et al. Benefits and Risks Associated With Continuation of Anti-Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease : A Nationwide Emulation Trial. Ann Intern Med 2022 Sep 27. doi: 10.7326/M22-0819.
PMID: 36162111